Li, W., Shenkar, R., Detter, M. R., Moore, T., Benavides, C., Lightle, R., … Awad, I. A. (2021). Propranolol inhibits cavernous vascular malformations by β1 adrenergic receptor antagonism in animal models. J Clin Invest, 131(19). https://doi.org/10.1172/JCI154909

Li, Wenqing, Robert Shenkar, Mathew R. Detter, Thomas Moore, Christian Benavides, Rhonda Lightle, Romuald Girard, et al. “Propranolol inhibits cavernous vascular malformations by β1 adrenergic receptor antagonism in animal models.” J Clin Invest 131, no. 19 (October 1, 2021). https://doi.org/10.1172/JCI154909.

Li W, Shenkar R, Detter MR, Moore T, Benavides C, Lightle R, et al. Propranolol inhibits cavernous vascular malformations by β1 adrenergic receptor antagonism in animal models. J Clin Invest. 2021 Oct 1;131(19).

Li, Wenqing, et al. “Propranolol inhibits cavernous vascular malformations by β1 adrenergic receptor antagonism in animal models.” J Clin Invest, vol. 131, no. 19, Oct. 2021. Pubmed, doi:10.1172/JCI154909.

Li W, Shenkar R, Detter MR, Moore T, Benavides C, Lightle R, Girard R, Hobson N, Cao Y, Li Y, Griffin E, Gallione C, Zabramski JM, Ginsberg MH, Marchuk DA, Awad IA. Propranolol inhibits cavernous vascular malformations by β1 adrenergic receptor antagonism in animal models. J Clin Invest. 2021 Oct 1;131(19).